Barrington Research Maintains Outperform on US Physical Therapy, Raises Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
Barrington Research analyst Michael Petusky has maintained an Outperform rating on US Physical Therapy (NYSE:USPH) and increased the price target from $111 to $120.
January 03, 2024 | 3:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barrington Research analyst Michael Petusky has reaffirmed an Outperform rating on US Physical Therapy and raised the price target from $111 to $120.
The increase in price target by Barrington Research suggests a positive outlook on the company's performance, which could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100